late-stage trials

Oncology

Biotech must build manufacturing and trial models that make cell therapies scalable, accessible & commercially viable.

Market Access

At BIO-Europe, the session “From Roasts to Billions: Biopharma Investment Landscape” brought together leading voices from investment banking & VC.

News

In a handful of strongly-worded warning letters, the FDA is cracking down on sales of unapproved peptides - even if they're labelled for research.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.